GlaxoSmithKline: Premature Birth trials
The registry lists 12 Premature Birth studies with GlaxoSmithKline as lead sponsor. 0 are open to participants now and 5 have results posted.
Phase 1 7Phase 2 1Phase 3 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Phase III Efficacy and Safety Study of Intravenous Retosiban Versus Placebo for Women in Spontaneous Preterm LaborTerminatedNCT02377466Phase 3Results posted
- Follow up Study to Assess Long Term Safety and Outcomes in Infants and Children Born to Mothers Participating in Retosiban Treatment StudiesCompletedNCT02292784Phase 3Results posted
- A Randomized Study Comparing the Efficacy and Safety of Retosiban Versus Atosiban for Women in Spontaneous Preterm LabourTerminatedNCT02292771Phase 3Results posted
- The Safety, Tolerability And Metabolism Of GSK221149A, In Pregnant Women (30-36 Weeks), In Pre-Term LaborCompletedNCT00404768Phase 2Results posted
- Study to Evaluate the Safety and Immunogenicity of a 10-valent Pneumococcal Conjugate Vaccine in Preterm InfantsCompletedNCT00390910Phase 3Results posted
- Study to Investigate the Pharmacokinetics (PK), Safety and Tolerability of Retosiban in Healthy Japanese WomenCompletedNCT02377414Phase 1
- A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Retosiban (GSK221149) When Dosed With Efavirenz (EFZ)CompletedNCT01867996Phase 1
- This Study Will Investigate the Effect of Single Oral Doses of Retosiban on Cardiac Repolarization, With Moxifloxacin as a Positive Control in Healthy Volunteers.CompletedNCT01702376Phase 1
- A Two Cohort Study to Look at the Metabolites of GSK221149, the Metabolism of GSK221149 Administered With a High Fat Meal and With KetoconazoleCompletedNCT01627587Phase 1
- A First Time in Human Study in Healthy Male Volunteers for Compound GSK557296.CompletedNCT00549211Phase 1
- Absorption, Distribution, Metabolism And Excretion Study For GSK221149ACompletedNCT00457925Phase 1
- A Study To Assess The Pharmacokinetics Of Different Modified Release Formulations Of GSK221149 In Healthy Adult SubjectsTerminatedNCT00449709Phase 1